The US Food and Drug Administration (FDA) has approved an over-the-counter version of the opioid overdose reversal drug naloxone, increasing access to the lifesaving medication and providing an additional option for those who may not have access to a prescription or a pharmacy. This move is expected to reduce opioid overdose deaths throughout the country, and Dr. Scott Hadland, a pediatrician and an addiction specialist at MassGeneral Hospital for Children in Boston, believes it could save more lives. The FDA remains committed to addressing the evolving complexities of the overdose crisis.
